Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
Category: Drugs (Pharmaceuticals)
-
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
The New York Times – Business: -
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
The New York Times – Business:AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
-
Start-Up Raises $200 Million to Speed Up Drug Trials
The New York Times – Business:New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
-
New Lawsuit Challenges State Bans on Abortion Pills
The New York Times – Business:The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
-
A Dilemma for Governments: How to Pay for Million-Dollar Therapies
The New York Times – Business:A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
-
Those Weight Loss Drugs May Do a Number on Your Face
The New York Times – Fashion & Style:People using drugs like Ozempic are discovering an unwanted side affect: facial aging.
-
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
The New York Times – Business:Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.
-
California Sues Companies Over Insulin Prices, Joining Other States
The New York Times – Business:The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
-
The Father of the Abortion Pill
The New York Times – Business:The 96-year-old scientist who came up with an idea for an “unpregnancy pill” decades ago has led an eventful life, from his teenage days in the French Resistance to his friendships with famous artists.
-
Medicare Begins to Rein In Drug Costs for Older Americans
The New York Times – Business:Reforms embedded in the Inflation Reduction Act will bring savings to seniors this year. Already some lawmakers are aiming to repeal the changes.
-
F.D.A. Approves New Treatment for Early Alzheimer’s
The New York Times – Business:The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
-
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says
The New York Times – Business:Mifepristone, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies. Now, if local drugstores or chains like CVS agree to certain rules, they can provide it.